2 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 4 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow VRD: new trials by email Literature Review of VRD trials Research Report on VRD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells Isatuximab, VRD - Multiple Myeloma | Phase 2 / Phase 3 | Not yet recruiting | The Affiliated People's Hospital of Ningbo University | 15 | 2027-01-01 | 2026-10-02 |
| VR Augmented Human Delivered Integrative Psychotherapy for Colonoscopy Procedural Anxiety and Pain Virtual Reality Integrative Psychotherapy, Virtual Reality Distraction - Procedural Anxiety, Procedural Pain | Not applicable | Terminated | Grigore T. Popa University of Medicine and Pharmacy | 36 | 2024-06-01 | 2026-07-30 |
| The Effect of Virtual Reality Distraction on Pain During Colonoscopy VRD - Valid MeSH Conditions | Not applicable | Completed | Max Healthcare Insititute Limited | 84 | 2023-10-03 | 2026-03-27 |
| A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma anti-BCMA CAR-T, VRd - Multiple Myeloma | Phase 2 | Active not recruiting | Institute of Hematology & Blood Diseases Hospital, China | 40 | 2023-04-04 | 2025-08-03 |
| Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients Chidamide+VRD, VRD - Multiple Myeloma | Phase 1 / Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 50 | 2019-07-15 | 2019-07-19 |
| a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell Transplantation x 1 or x 2, Melphalan Given IV - Multiple Myeloma, Plasma Cell Leukemia | Not applicable | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 50 | 2018-01-05 | 2019-07-05 |
| VR High Tech Pain Control Burn Wound Care Virtual Reality Distraction, Audio (sound of nature), Control standard nurse wound care - Pain, Burn | Not applicable | Completed | National Institute of General Medical Sciences (NIGMS) | 8 | 2011-11-01 | 2019-03-13 |
Multiple Myeloma (4) · Pain (2) · Anxiety Disorders (1) · Burns (1) · Chromosome 17 deletion (1) · Leukemia, Plasma Cell (1) · Pain, Procedural (1)
Institute of Hematology & Blood Diseases Hospital, China (2) · Grigore T. Popa University of Medicine and Pharmacy (1) · Max Healthcare Insititute Limited (1) · National Institute of General Medical Sciences (NIGMS) (1) · The Affiliated People's Hospital of Ningbo University (1) · The First Affiliated Hospital of Soochow University (1)
China (3) · India (1) · Romania (1) · United States (1)
Cristinel Stefanescu, Prof. MD (1) · David R. Patterson, Ph.D. (1) · Lu G Qiu, Dr. (1) · Marcel A Gaina, ass.prof. MD (1) · Vivek Raj, MD, FRCP (1)